Technology
Health
Pharmaceutical

Immunic

$15.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$8.45 (90.86%) Today
-$2.25 (-12.68%) After Hours

Why Robinhood?

You can buy or sell Immunic and other stocks, options, ETFs, and crypto commission-free!

About

Immunic, Inc. engages in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Read More Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

Employees
10
Headquarters
San Diego, California
Founded
Market Cap
9.85M
Price-Earnings Ratio
Dividend Yield
Average Volume
112.72K
High Today
$18.77
Low Today
$9.30
Open Price
$9.30
Volume
1.60M
52 Week High
$390.00
52 Week Low
$6.04

Collections

Technology
Health
Pharmaceutical
2014 IPO
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.